,,ii  #aaith ,,congress  #b;d ,session  
,s4 #dida  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,june #bd1     
#bjbf,mr4 ,markey 7for himself1 ,mr4    
,paul1 ,ms4 ,warren1 ,ms4 ,hassan1 ,ms4 
,duckworth1 and ,mr4 ,booker7 introduced
 the following bill2 which was read     
twice and referred to the ,committee on 
,health1 ,education1 ,labor1 and        
,pensions  ,a ,,bill  ,to expand access 
to methadone through alternative care   
models using pharmacies4  #a4 ,short    
title ,this ,act may be cited as the    
,modernizing ,opioid ,treatment ,access 
,act #b4j of #bjbf4  #b4 ,expansion of  
methadone for opioid use disorder       
through prescribing and pharmacies      
,section #cjc7;h7 of the ,controlled    
,substances ,act 7#ba ,u4,s4,c4         
#hbc7;h77 is amended-- 7#a7 in paragraph
 7#b7-- 7,a7 by striking 7,a7 and       
inserting 7i72 and  7,b7 by striking    
7,b7 and inserting 7ii72  7#b7 by       
redesignating paragraphs 7#a71 7#b71 and
 7#c7 as subparagraphs 7,a71 7,b71 and  

7,c71 respectively2  7#c7 by striking   
7h7 ,practitioners and inserting 7h77#a7
 ,practitioners2 and  7#d7 by adding at 
the end the following3  7#b7 7,a7 ,the  
requirements of paragraph 7#a7          
applicable to methadone medication for  
opioid use disorder are waived1 and the 
,attorney ,general1 in consultation with
 the ,secretary1 shall separately       
register practitioners described in     
subparagraph 7,b7 of this paragraph to  
prescribe methadone for opioid use      
disorder to be dispensed through a      
pharmacy to individuals for their own   
supervised or unsupervised use4  7,b7   
,practitioners described in this        
subparagraph are persons who-- 7i7 are  
licensed1 registered1 or otherwise      
permitted1 by the ,united ,states or the
 jurisdiction in which they practice1 to
 prescribe controlled substances in the 
course of professional practice2 and    
7ii7 are-- 7,i7 addiction medicine      
physicians or addiction psychiatrists   
who hold a subspecialty board           

certification in addiction medicine from
 the ,american ,board of ,preventive    
,medicine1 a board certification in     
addiction medicine from the ,american   
,board of ,addiction ,medicine1 a       
subspecialty board certification in     
addiction psychiatry from the ,american 
,board of ,psychiatry and ,neurology1 or
 a subspecialty board certification in  
addiction medicine from the ,american   
,osteopathic ,association2 or  7,,ii7   
otherwise determined by the ,secretary1 
under standards established by the      
,secretary1 to be qualified to prescribe
 methadone for opioid use disorder4     
7,c7 ,the prescribing of methadone      
pursuant to subparagraph 7,a7 shall be--
 7i7 exclusively by electronic          
prescribing and dispensed to the        
individual treated pursuant to          
subparagraph 7,a72  7ii7 in compliance  
with applicable ,federal and ,state law 
respecting the quantities of methadone  
for opioid use disorder that may be     
dispensed to individuals pursuant to    

subparagraph 7,a72 and  7iii7 for a     
liquid or dispersible tablet            
formulation4  7,d7 ,the dispensing of   
methadone to an individual pursuant to  
subparagraph 7,a7 shall be in addition  
to the other care that the individual   
continues to have access to through an  
opioid use disorder treatment program4  
7,e7 ,practitioners registered pursuant 
to subparagraph 7,a7 shall-- 7i7 ensure 
and document1 with respect to each      
individual treated pursuant to          
subparagraph 7,a71 informed consent to  
treatment2 and  7ii7 include in such    
informed consent1 specific informed     
consent regarding differences in        
confidentiality protections applicable  
when dispensing through an opioid       
treatment program versus dispensing     
through a pharmacy pursuant to          
subparagraph 7,a74  7,f7 ,at the request
 of a ,state1 the ,attorney ,general    
shall-- 7i7 cease registering persons in
 the ,state pursuant to subparagraph    
7,a72  7ii7 revoke any such registration

 in effect for a person in the ,state   
pursuant to section #cjd2 and  7iii7    
deny any pending application for such   
registration from a practitioner in the 
,state pursuant to section #cjd4  7,g7  
,maintenance treatment or detoxification
 treatment provided pursuant to         
subparagraph 7,a7 may be provided       
through the practice of telemedicine4   
7,h7 ,a pharmacy shall not be required  
to obtain a separate registration to    
dispense methadone medication for opioid
 use disorder to an individual who has  
been prescribed that medication by a    
practitioner registered pursuant to     
subparagraph 7,a74  7#c7 ,not later than
 #ahj days after the date of enactment  
of this paragraph1 and annually         
thereafter1 the ,administrator of the   
,drug ,enforcement ,administration shall
 submit to ,congress a report that      
includes1 for the reporting period--    
7,a7 the number of practitioners        
registered pursuant to paragraph        
7#b77;,a7 in each ,state2  7,b7 a list  

of ,states for which the ,attorney      
,general received a request pursuant to 
paragraph 7#b77;,f72  7,c7 the number of
 revocations or suspensions of          
registration issued pursuant to section 
#cjd1 based on violations related to the
 prescribing of methadone for opioid use
 disorder by practitioners who are      
registered pursuant to paragraph        
7#b77;,a72 and  7,d7 the number of      
pharmacies that ordered methadone in    
liquid or dispersible tablet            
formulations4  4  #c4 ,effective date   
,this ,act and the amendments made by   
this ,act shall take effect on the date 
that is #ahj days after the date of     
enactment of this ,act4